LobbyingEyepoint Pharmaceuticals lobbying by quarter
Eyepoint Pharmaceuticals's latest lobbying report covers Q2 2023, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
Eyepoint Pharmaceuticals
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $80K | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Medicare and Medicaid3 reports
- Health issues1 reports
A report that names several issues counts once for each.
Who was lobbied
- Health & Human Services, Dept of (HHS)3 reports
- HOUSE OF REPRESENTATIVES3 reports
- SENATE3 reports
Firms it paid
| Firm | ||
|---|---|---|
| Forbes-Tate | $80K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| MICHAEL ALEXANDER WILLIAMS | Legislative Director, Rep. Lucy McBath (2021-2022); Legislative Assistant, Rep. Lucy McBath (2019-2020); Legislative Aide, Sen. Brian Jones (2019); Legislative Correspondent, Sen. Brian Jones (2018-2019) | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 23/07/16for Q2 2023 | Forbes-Tate | Under $5,000 |
| 23/04/17for Q1 2023 | Forbes-Tate | Under $5,000 |
| 23/01/15for Q4 2022 | Forbes-Tate | $80K |